Severe Asthma FDA Approvals, Clinical Trials, Emerging Drugs, Pipeline Insights and Companies | DelveInsight
The leading Severe Asthma Companies such as Kinaset Therapeutics, Bio-Thera Solutions, CSPC ZhongQi Pharmaceutical Technology ...
pulmonologyadvisor15h
Rhinoconjunctivitis in Children With Asthma May Not Always Be Allergy Driven
Phenotyping children with asthma based on rhinoconjunctivitis symptoms shows that rhinoconjunctivitis may not always be allergy driven.
The Lancet4d
Chronic obstructive pulmonary disease: new therapies and old needs
Chronic obstructive pulmonary disease (COPD) is a manifestation of structural violence, the process through which societies ...
Too Old to Operate5d
Novel Asthma Burden Score Accurately Predicts Remission
A novel asthma burden score accurately assesses asthma severity and predicts remission, according to findings published in The Lancet Respiratory Medicine.
Options Available For Adolescents With Asthma At BioBehavioral Research Of Austin
Dr. Neha Reshamwala, owner of Frontier Allergy, Asthma & Immunology, with BioBehavioral Research of Austin (BBRA) stopped by ...
Le Lézard5d
Ethris Presents Positive Topline Phase 1 Data with mRNA Lead Candidate ETH47 for Uncontrolled Asthma
Ethris GmbH, a leading biotechnology company pioneering next-generation RNA therapeutics and vaccines, today announced promising topline data from the completed Phase 1 clinical trial of its lead mRNA ...
EMA Accepts GSK's Filing for Depemokimab in Two Respiratory Diseases
If approved, GSK's depemokimab will be the first ultra-long-acting biologic that requires only one dose every six months.